Skip to search.
 BSE Up 1.58% NSE Up 1.56%
Streaming
Ticker Tape: On

Celgene Corporation (CELG)

-NasdaqGS
141.51 Down 0.35(0.25%) 18 Apr 1:30AM
|After Hours : 141.46 Down 0.05 (0.04%) 18 Apr 5:22AM
Add to Portfolio
Prev Close:141.86
Open:141.98
Bid:140.50 x 100
Ask:143.26 x 500
1y Target Est:193.21
Beta:1.08
Next Earnings Date:24-Apr-14CELG Earnings announcement
Day's Range:140.29 - 144.07
52wk Range:110.53 - 174.66
Volume:2,974,766
Avg Vol (3m):3,911,880
Market Cap:57.46B
P/E (ttm):41.99
EPS (ttm):3.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.25%57.46B
JNJUp 0.21%279.95B

Key Statistics

Forward P/E (1 yr):14.77
P/S (ttm):8.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.28
Quarterly EPS Est (Mar-14) :1.65
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback